Kato S - Search Results

1

Factors contributing to salivary human immunodeficiency virus type-1 levels measured by a Poisson distribution-based PCR method.

Ikeno R, Yamada E, Yamazaki S, Ueda T, Nagata M, Takagi R, Kato S. Ikeno R, et al. Among authors: kato s. J Int Med Res. 2018 Mar;46(3):996-1007. doi: 10.1177/0300060517728652. Epub 2017 Nov 9. J Int Med Res. 2018. PMID: 29119839 Free PMC article.

2

Complete removal of HIV-1 RNA and proviral DNA from semen by the swim-up method: assisted reproduction technique using spermatozoa free from HIV-1.

Kato S, Hanabusa H, Kaneko S, Takakuwa K, Suzuki M, Kuji N, Jinno M, Tanaka R, Kojima K, Iwashita M, Yoshimura Y, Tanaka K. Kato S, et al. AIDS. 2006 Apr 24;20(7):967-73. doi: 10.1097/01.aids.0000222067.07255.2d. AIDS. 2006. PMID: 16603847

3

Prediction of the efficacy of antiviral therapy for hepatitis C virus infection by an ultrasensitive RT-PCR assay.

Kinai E, Hanabusa H, Kato S. Kinai E, et al. Among authors: kato s. J Med Virol. 2007 Aug;79(8):1113-9. doi: 10.1002/jmv.20908. J Med Virol. 2007. PMID: 17596840

4

Intracellular efavirenz levels in peripheral blood mononuclear cells from human immunodeficiency virus-infected individuals.

Tanaka R, Hanabusa H, Kinai E, Hasegawa N, Negishi M, Kato S. Tanaka R, et al. Among authors: kato s. Antimicrob Agents Chemother. 2008 Feb;52(2):782-5. doi: 10.1128/AAC.01613-06. Epub 2007 Dec 10. Antimicrob Agents Chemother. 2008. PMID: 18070970 Free PMC article.

5

Determination of abacavir, tenofovir, darunavir, and raltegravir in human plasma and saliva using liquid chromatography coupled with tandem mass spectrometry.

Yamada E, Takagi R, Sudo K, Kato S. Yamada E, et al. Among authors: kato s. J Pharm Biomed Anal. 2015 Oct 10;114:390-7. doi: 10.1016/j.jpba.2015.06.005. Epub 2015 Jun 10. J Pharm Biomed Anal. 2015. PMID: 26112927

6

Qualitative Real-Time PCR Assay for HIV-1 and HIV-2 RNA.

Yamazaki S, Kondo M, Sudo K, Ueda T, Fujiwara H, Hasegawa N, Kato S. Yamazaki S, et al. Among authors: kato s. Jpn J Infect Dis. 2016 Sep 21;69(5):367-72. doi: 10.7883/yoken.JJID.2015.309. Epub 2016 Jan 8. Jpn J Infect Dis. 2016. PMID: 26743143 Free article.

7

Plasma and saliva concentrations of abacavir, tenofovir, darunavir, and raltegravir in HIV-1-infected patients .

Yamada E, Takagi R, Tanabe Y, Fujiwara H, Hasegawa N, Kato S. Yamada E, et al. Among authors: kato s. Int J Clin Pharmacol Ther. 2017 Jul;55(7):567-570. doi: 10.5414/CP202789. Int J Clin Pharmacol Ther. 2017. PMID: 28427498

8

Saliva as a potential matrix for evaluating pharmacologically active dolutegravir concentration in plasma.

Yamada E, Takagi R, Moro H, Sudo K, Kato S. Yamada E, et al. Among authors: kato s. PLoS One. 2021 Feb 18;16(2):e0246994. doi: 10.1371/journal.pone.0246994. eCollection 2021. PLoS One. 2021. PMID: 33600473 Free PMC article.

9

Differential prevalence of HIV type 1 subtype B and CRF01_AE among different sexual transmission groups in Tokyo, Japan, as revealed by subtype-specific PCR.

Kato S, Saito R, Hiraishi Y, Kitamura N, Matsumoto T, Hanabusa H, Kamakura M, Ikeda Y, Negishi M. Kato S, et al. AIDS Res Hum Retroviruses. 2003 Nov;19(11):1057-63. doi: 10.1089/088922203322588431. AIDS Res Hum Retroviruses. 2003. PMID: 14686327

10

A simple competitive RT-PCR assay for quantitation of HIV-1 subtype B and non-B RNA in plasma.

Hamatake M, Nishizawa M, Yamamoto N, Kato S, Sugiura W. Hamatake M, et al. Among authors: kato s. J Virol Methods. 2007 Jun;142(1-2):113-7. doi: 10.1016/j.jviromet.2007.01.012. Epub 2007 Mar 23. J Virol Methods. 2007. PMID: 17367872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,159 results

Search Page

Filters